Amgen To Present At The 15th Annual Citi BioPharma Conference

Rhea-AI Summary

Amgen will present at Citi's 15th Annual Virtual BioPharma Conference on September 10, 2020, at 2:25 p.m. ET. Key executives, Murdo Gordon and Peter H. Griffith, will deliver the presentation. Interested parties can access live audio via Amgen's website, with a replay available for 90 days post-event. Founded in 1980, Amgen is a leading biotechnology company focused on innovative therapeutics, emphasizing solutions for serious illnesses and unmet medical needs. For more details, visit www.amgen.com.

News Market Reaction – AMGN

-2.91%

-2.91% Session move

In the trading session that priced this news, AMGN declined 2.91%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

THOUSAND OAKS, Calif., Sept. 4, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at Citi's 15th Annual Virtual BioPharma Conference at 2:25 p.m. ET on Thursday, Sept. 10, 2020. Murdo Gordon, executive vice president of Global Commercial Operations at Amgen and Peter H. Griffith, executive vice president and chief financial officer, will present at the conference. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, www.amgen.com, under Investors. A replay of the webcast will also be available on Amgen's website for at least 90 days following the event.

About Amgen 
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.  

CONTACT: Amgen, Thousand Oaks 
Megan Fox, 805-447-1423 (media)
Trish Rowland, 805-447-5631(media) 
Arvind Sood, 805-447-1060 (investors) 

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/amgen-to-present-at-the-15th-annual-citi-biopharma-conference-301124644.html

SOURCE Amgen

FAQ

When is Amgen's presentation at the Citi BioPharma Conference?

Amgen will present at the Citi's 15th Annual Virtual BioPharma Conference on September 10, 2020, at 2:25 p.m. ET.

Who from Amgen will present at the conference?

Murdo Gordon and Peter H. Griffith will present for Amgen at the conference.

How can I access the presentation of Amgen at the Citi BioPharma Conference?

The live audio of the presentation can be accessed on Amgen's website under the Events Calendar.

Is there a replay available for Amgen's conference presentation?

Yes, a replay of the webcast will be available on Amgen's website for at least 90 days after the event.

What is Amgen's focus in the biotechnology sector?

Amgen focuses on discovering, developing, and delivering innovative therapeutics for patients with serious illnesses.